EVAXION BIOTECH ($EVAX) posted quarterly earnings results for Q2 2026 on Thursday, August 20th. The company reported earnings of -$0.50 per share, missing estimates of -$0.32 by $0.18. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $EVAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EVAXION BIOTECH Hedge Fund Activity
We have seen 6 institutional investors add shares of EVAXION BIOTECH stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 33,100 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $123,132
- J. SAFRA SARASIN HOLDING AG added 22,896 shares (+inf%) to their portfolio in Q2 2026, for an estimated $70,977
- JANE STREET GROUP, LLC added 20,581 shares (+inf%) to their portfolio in Q2 2026, for an estimated $63,801
- CITADEL ADVISORS LLC added 18,811 shares (+105.8%) to their portfolio in Q2 2026, for an estimated $58,314
- XTX TOPCO LTD removed 9,154 shares (-41.5%) from their portfolio in Q2 2026, for an estimated $28,377
- UBS GROUP AG added 6,275 shares (+inf%) to their portfolio in Q2 2026, for an estimated $19,452
- RENAISSANCE TECHNOLOGIES LLC removed 5,425 shares (-13.8%) from their portfolio in Q2 2026, for an estimated $16,817
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
EVAXION BIOTECH Price Targets
Multiple analysts have issued price targets for $EVAX recently. We have seen 3 analysts offer price targets for $EVAX in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $16.0 on 04/24/2026
- An analyst from Jones Trading set a target price of $10.0 on 03/10/2026
- Thomas Flaten from Lake Street set a target price of $9.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
